查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1980797

2026-2034年全球輔助生殖技術市場規模、佔有率、趨勢和成長分析報告

Global Assisted Reproductive Technology Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 138 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

輔助生殖技術（ART）市場預計將從 2025 年的 515.8 億美元成長到 2034 年的 1,245.5 億美元，2026 年至 2034 年的複合年成長率為 10.29%。

近年來，受不孕症發病率上升和人們對先進不孕症治療方法認知度提高的推動，全球輔助生殖技術（ART）市場經歷了顯著成長。晚育、生活方式改變以及影響生育能力的疾病等因素，都促使人們對包括體外受精（IVF）和卵胞漿內單一精子注射（ICSI）在內的輔助生殖技術的需求不斷成長。不孕症治療接受度的提高和成功率的提升，也鼓勵了更多夫婦選擇輔助生殖技術。

生殖醫學領域的技術進步在輔助生殖技術（ART）市場的擴張中發揮了至關重要的作用。諸如延時胚胎成像、基因篩檢和冷凍保存等創新技術提高了治療效果，增強了患者的信心。此外，已開發國家和發展中國家生育診所和專業生殖醫學中心的擴張，提高了獲得ART服務的機會，並進一步推動了市場成長。

展望未來，由於多個國家加大對不孕症研究的投入以及政府的支持措施，預計市場將強勁成長。此外，單親家庭和同性伴侶撫養子女的社會接受度不斷提高，預計也將推動對輔助生殖技術（ART）服務的需求成長。同時，生殖技術的進步和治療成本的降低，預計在未來幾年為市場相關人員創造巨大的商機。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球輔助生殖科技市場：依方法分類

  • 市場分析、洞察與預測
  • 體外受精（IVF）
  • 人工授精（AI-IUI）
  • 冷凍胚胎移植（FET）
  • 其他

第5章：全球輔助生殖技術市場：依手術類型分類

  • 市場分析、洞察與預測
  • 新鮮捐贈者
  • 非新鮮捐贈者
  • 冷凍捐贈者
  • 非冷凍捐贈者

第6章：全球輔助生殖科技市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 醫院
  • 不孕症治療診所

第7章 全球輔助生殖科技市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Bloom IVF Centre
    • California Cryobank
    • CARE Fertility
    • Monash IVF Group
    • Carolinas Fertility Institute
    • European Sperm Bank
    • INVO Bioscience
    • Apollo Hospitals Enterprise Ltd
    • The Cooper Companies
    • Vitrolife AB
簡介目錄
Product Code: VMR112115483

The Assisted Reproductive Technology Market size is expected to reach USD 124.55 Billion in 2034 from USD 51.58 Billion (2025) growing at a CAGR of 10.29% during 2026-2034.

The global Assisted Reproductive Technology (ART) market has experienced significant growth in recent years due to the rising prevalence of infertility and increasing awareness about advanced fertility treatments. Factors such as delayed parenthood, lifestyle changes, and medical conditions affecting fertility have contributed to higher demand for ART procedures including in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). Growing acceptance of fertility treatments and improved success rates have also encouraged more couples to consider assisted reproductive options.

Technological advancements in reproductive medicine have played a crucial role in expanding the ART market. Innovations such as time-lapse embryo imaging, genetic screening technologies, and cryopreservation techniques have improved treatment outcomes and increased patient confidence. Additionally, the expansion of fertility clinics and specialized reproductive centers across developed and developing regions is enhancing accessibility to ART procedures, further driving market growth.

Looking ahead, the market is expected to witness strong expansion due to increasing investments in fertility research and supportive government initiatives in several countries. Growing social acceptance of single parenthood and same-sex parenting is also expected to boost demand for ART services. Furthermore, advancements in reproductive technologies and improved affordability of treatments are likely to create significant opportunities for market players in the coming years.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technique

  • In Vitro Fertilization (IVF)
  • Artificial Insemination (AI-IUI)
  • Frozen Embryo Transfer (FET)
  • Others

By Procedure

  • Fresh Donor
  • Fresh Non-donor
  • Frozen Donor
  • Frozen Non-donor

By End User

  • Hospitals
  • Fertility Clinics

COMPANIES PROFILED

  • Bloom IVF Centre, California Cryobank, CARE Fertility, Monash IVF Group, Carolinas Fertility Institute, European Sperm Bank, INVO Bioscience, Apollo Hospitals Enterprise Ltd, The Cooper Companies, Vitrolife AB
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: BY TECHNIQUE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Technique
  • 4.2. In Vitro Fertilization (IVF) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Artificial Insemination (AI-IUI) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Frozen Embryo Transfer (FET) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: BY PROCEDURE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Procedure
  • 5.2. Fresh Donor Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Fresh Non-donor Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Frozen Donor Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Frozen Non-donor Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: BY END USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End User
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Fertility Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Technique
    • 7.2.2 By Procedure
    • 7.2.3 By End User
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Technique
    • 7.3.2 By Procedure
    • 7.3.3 By End User
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Technique
    • 7.4.2 By Procedure
    • 7.4.3 By End User
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Technique
    • 7.5.2 By Procedure
    • 7.5.3 By End User
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Technique
    • 7.6.2 By Procedure
    • 7.6.3 By End User
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Bloom IVF Centre
    • 9.2.2 California Cryobank
    • 9.2.3 CARE Fertility
    • 9.2.4 Monash IVF Group
    • 9.2.5 Carolinas Fertility Institute
    • 9.2.6 European Sperm Bank
    • 9.2.7 INVO Bioscience
    • 9.2.8 Apollo Hospitals Enterprise Ltd
    • 9.2.9 The Cooper Companies
    • 9.2.10 Vitrolife AB